title: Outcome of pregnancy in renal allograft recipients: SIUT experience.
abstract: The course of pregnancy and its outcome was studied in renal allograft recipients. Between November 1985 and November 2005, a total of 1481 renal transplants were carried out at the Sindh Institute of Urology and Transplantation (SIUT); among them were 348 females, with 73 potential females for pregnancy. All patients received cyclosporine and prednisolone, with 82% also receiving azathioprine and 4 patients mycophenolate mofetil as a third immunosuppressant drug. We evaluated incidence of hypertension, diabetes, pre-eclampsia, urinary tract infection (UTI), rejection during pregnancy and during 3 months' postdelivery as well as outcomes of pregnancy. Among 73 potential candidates, 31 had 47 pregnancies, after an average of 31 months (8-86 months). Of 31 subjects, 21 subjects were hypertensive on one or two drugs prior to conception. A rise in blood pressure during pregnancy was noticed in 7 patients. Albuminuria from trace to 3+ appeared in 13 patients and glycosuria in one other. Blood sugar levels remained within normal range in all subjects. UTIs occurred during pregnancy in 7 patients. Among 47 pregnancies, 9 had abortions (7 spontaneous, 2 therapeutic) and 6 had preterm deliveries. The others were full-term deliveries: 12 via a lower segment caesarean section and 20 were normal vaginal deliveries. Average birth weight was 4.8 lbs. At an average follow-up of 38 months the serum creatinine values ranged from 0.94 to 2.3 mg %. One patient developed acute irreversible graft dysfunction soon after delivery. Our study demonstrated that pregnancy did not reduce renal graft survival, but newborns are at greater risk of premature birth and low birth weight.
authors.affiliation: Sindh Institute of Urology and Transplantation (SIUT), Civil Hospital, Karachi 74200, Pakistan. naqvirubina@yahoo.com
authors.forename: R
authors.initials: R
authors.lastname: Naqvi
authors.forename: H
authors.initials: H
authors.lastname: Noor
authors.forename: S
authors.initials: S
authors.lastname: Ambareen
authors.forename: H
authors.initials: H
authors.lastname: Khan
authors.forename: A
authors.initials: A
authors.lastname: Haider
authors.forename: N
authors.initials: N
authors.lastname: Jafri
authors.forename: A
authors.initials: A
authors.lastname: Alam
authors.forename: R
authors.initials: R
authors.lastname: Aziz
authors.forename: K
authors.initials: K
authors.lastname: Manzoor
authors.forename: T
authors.initials: T
authors.lastname: Aziz
authors.forename: E
authors.initials: E
authors.lastname: Ahmed
authors.forename: F
authors.initials: F
authors.lastname: Akhtar
authors.forename: A
authors.initials: A
authors.lastname: Naqvi
authors.forename: A
authors.initials: A
authors.lastname: Rizvi
mesh_terms: D000419:Albuminuria / Q000453:epidemiology; D002585:Cesarean Section / Q000706:statistics & numerical data; D036861:Delivery, Obstetric; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007231:Infant, Newborn; D007234:Infant, Premature; D016030:Kidney Transplantation; D011247:Pregnancy; D011248:Pregnancy Complications; D012189:Retrospective Studies; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents